Valued at a market cap of $29.6 billion, San Diego, California-based DexCom, Inc. (DXCM) is a medical device company ...

The agency approved the first CGM for over-the-counter use in March. Stelo, by Dexcom, was approved for anyone 18 and older ...

Waiting on Apple to add glucose tracking on a smartwatch to learn about your blood sugar? Don't. Try a biosensor instead.

24 analysts are following DexCom and have set target prices ranging from $75.0 to $120.0 per share. On average, they have ...

Progressing the development of a novel CGM sensor to the point where it can improve the quality of life for millions of people with diabetes can be a tall order. In order to build confidence that the ...

We recently published a list of 12 High Growth Large Cap Stocks to Buy Now. In this article, we are going to take a look at ...

Dexcom has rounded up its celebrity spokespeople for World Diabetes Day, putting singer Nick Jonas at the center of a ...

EXCLUSIVE The singer-songwriter and actor has crammed a lot into his 32 years of life and the ‘incredibly ambitious and ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

This World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging ...

US-based medical device firm Dexcom Inc has officially opened its new manufacturing facility in Batu Kawan, Penang, marking ...

Dexcom, founded in 1999, is a global leader in continuous glucose Monitoring (CGM) technology for individuals living with ...